Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes

Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes

Abstract Background Reports on the effects of renin–angiotensin–aldosterone system (RAAS) inhibitors on the clinical outcomes of coronavirus disease-19 (COVID-19) have been conflicting. We performed this meta-analysis to find conclusive evidence. Methods We searched published articles through PubMed...

Full description

Bibliographic Details
Main Authors: Yihienew M. Bezabih, Alemayehu Bezabih, Endalkachew Alamneh, Gregory M. Peterson, Woldesellassie Bezabhe
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Infectious Diseases
Subjects:
RAAS inhibitors
COVID-19
Coronavirus
Angiotensin
Clinical outcome
ACE2
Online Access:https://doi.org/10.1186/s12879-021-06088-6

Internet

https://doi.org/10.1186/s12879-021-06088-6

Similar Items